A

Active Director Director DIN 09359100
DIN 09359100 First appointment Oct 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Anushree

Data last updated:

Anushree is a Director at Tribune Healthcare Private Limited (since 2021). The company operates in Pharma. Tribune Healthcare Private Limited reported revenue of ₹24.5 Lakh (FY 2024).

DIN 09359100
Primary Designation Director
Industry Pharma
First Appointment 13 Oct 2021
Oldest Company Age 13 yrs
Largest company Tribune Healthcare Private Limited · ₹24.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tribune Healthcare Private Limited U24100DL2013PTC248804
Director13 Oct 20212013₹24.5 Lakh (FY 2024)Active

Board colleagues of Anushree

Directorship timeline

Open interactive timeline →
Tribune Healthcare Private Limited
Premium access

Shareholding and investment profile for Anushree

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anushree

Anushree currently holds 1 directorship: Tribune Healthcare Private Limited (Director, since 13 Oct 2021, revenue ₹24.5 Lakh (FY 2024)).

Anushree was first appointed on 13 Oct 2021 as Director at Tribune Healthcare Private Limited.

The current boards of Anushree's companies include Ajeet Kumar Gupta (Tribune Healthcare Private Limited), Ayush Agrawal (Tribune Healthcare Private Limited), Sanjay Kumar (Tribune Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available